These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 4471640

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Failure of immunotherapy with neuraminidase-treated tumor cell vaccine in mice bearing established 3-methylcholanthrene-induced sarcomas.
    Spence RJ, Simon RM, Baker AR.
    J Natl Cancer Inst; 1978 Feb; 60(2):451-9. PubMed ID: 621758
    [Abstract] [Full Text] [Related]

  • 23. Failure of Bacillus Calmette-Guérin (BCG) infection to suppress the growth of transplanted mouse and rat sarcomas.
    Símová J, Bubeník J.
    Folia Biol (Praha); 1973 Feb; 19(4):296-300. PubMed ID: 4356560
    [No Abstract] [Full Text] [Related]

  • 24. Action of Bacillus Calmette Guerin vaccine. II. Mechanisms to mount effective immune response against neoplastic proliferation.
    Hakin AA.
    Pharm Acta Helv; 1976 Feb; 51(4):98-105. PubMed ID: 184479
    [No Abstract] [Full Text] [Related]

  • 25. [Immunotherapeutic effect of orally administered BCG on experimental lung metastasis of subcutaneous fibrosarcoma in guinea pigs].
    Fujisawa S.
    Nihon Hifuka Gakkai Zasshi; 1982 Feb; 92(8):871-81. PubMed ID: 6983601
    [No Abstract] [Full Text] [Related]

  • 26. Effect of bacille Calmette-Guerin immunotherapy on feline sarcoma virus-induced neoplasms in the cat.
    Bachman D, Cockerell GL, de Noronha F, Rapp HJ.
    Am J Vet Res; 1982 Mar; 43(3):475-80. PubMed ID: 6280529
    [Abstract] [Full Text] [Related]

  • 27. Tumor regression after intralesional injection of mycobacterial components emulsified in 2,6,10,15,19,23-hexamethyl-2,6,10,14,18,22-tetracosahexaene (squalene), 2,6,10,15,19,23-hexamethyltetracosane (squalane), peanut oil, or mineral oil.
    Yarkoni E, Rapp HJ.
    Cancer Res; 1979 May; 39(5):1518-20. PubMed ID: 427795
    [Abstract] [Full Text] [Related]

  • 28. [Anti-tumor activity of BCG-CWS].
    Ogura T, Sakaya M, Naniwa M, Yamamura Y.
    Kekkaku; 1980 Oct; 55(10):470-2. PubMed ID: 7230588
    [No Abstract] [Full Text] [Related]

  • 29. BCG immunotherapy: effects of dose and route of administration in mice bearing established tumors.
    Codish SD, Monaco AP.
    Surg Forum; 1976 Oct; 27(62):150-2. PubMed ID: 1019836
    [No Abstract] [Full Text] [Related]

  • 30. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment.
    Alvarez V, Lodillinsky C, Umerez S, Sandes E, Eiján AM.
    Int J Mol Med; 2005 Oct; 16(4):565-71. PubMed ID: 16142388
    [Abstract] [Full Text] [Related]

  • 31. Immunotherapy with neuraminidase-treated cells and bacillus Calmette-Guerin.
    Kollmorgen GM, Killion JJ, Sansing WA, Cantrell JL, Bundren JC, LeFever AV.
    Surgery; 1976 Feb; 79(02):202-8. PubMed ID: 1108258
    [Abstract] [Full Text] [Related]

  • 32. Immunological studies in murine osteosarcoma. Immunogenicity, growth kinetics, and immunotherapy.
    Miller CW, DeBlasi RF, Fisher SJ.
    J Bone Joint Surg Am; 1976 Apr; 58(3):312-7. PubMed ID: 1063129
    [Abstract] [Full Text] [Related]

  • 33. High resistance induced by young live Bacillus Calmette-Guérin (BCG) to Schistosoma mansoni infection in mice.
    Bout D, Dupas H, Carlier Y, Afchain D, Capron A.
    Ann Immunol (Paris); 1977 Apr; 128C(4-5):811-6. PubMed ID: 900893
    [Abstract] [Full Text] [Related]

  • 34. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
    Udagawa M, Kudo-Saito C, Hasegawa G, Yano K, Yamamoto A, Yaguchi M, Toda M, Azuma I, Iwai T, Kawakami Y.
    Clin Cancer Res; 2006 Dec 15; 12(24):7465-75. PubMed ID: 17189420
    [Abstract] [Full Text] [Related]

  • 35. Therapeutic effect of intratumoral injection of bcg and other substances in rats and mice.
    Chassoux D, Salomon JC.
    Int J Cancer; 1975 Oct 15; 16(4):515-25. PubMed ID: 1176205
    [Abstract] [Full Text] [Related]

  • 36. Effect of Myobacterium bovis (strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice.
    Fisher B, Taylor S, Levine M, Saffer E, Fisher ER.
    Cancer Res; 1974 Jul 15; 34(7):1668-70. PubMed ID: 4599359
    [No Abstract] [Full Text] [Related]

  • 37. [Effect of BCG (Bacillus Calmette Guérin) sensitization on the generation of tumor specific killer T cells].
    Takeuchi M, Kimoto M, Suzuki I, Nomoto K.
    Gan To Kagaku Ryoho; 1983 Sep 15; 10(9):1980-6. PubMed ID: 6604499
    [Abstract] [Full Text] [Related]

  • 38. Effect of BCG on fibrosarcoma.
    Gupta N, Sehgal S.
    Indian J Exp Biol; 1987 Dec 15; 25(12):811-5. PubMed ID: 3453810
    [No Abstract] [Full Text] [Related]

  • 39. Immunotherapy for bladder cancer using recombinant bacillus Calmette-Guerin DNA vaccines and interleukin-12 DNA vaccine.
    Lee CF, Chang SY, Hsieh DS, Yu DS.
    J Urol; 2004 Mar 15; 171(3):1343-7. PubMed ID: 14767345
    [Abstract] [Full Text] [Related]

  • 40. Genetically regulated response to intravesical bacillus Calmette Guerin immunotherapy of orthotopic murine bladder tumor.
    Kadhim SA, Chin JL, Batislam E, Karlik SJ, Garcia B, Skamene E.
    J Urol; 1997 Aug 15; 158(2):646-52. PubMed ID: 9224385
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.